Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Breast Neoplasms 11Leukemia, Myeloid, Acute 9Congenital Abnormalities 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Multiple Myeloma 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Waldenstrom Macroglobulinemia 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Colorectal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Burkitt Lymphoma 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Lung Neoplasms 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Central Nervous System Neoplasms 4Blast Crisis 4Sezary Syndrome 3

Interventions

Temozolomide 131Radiotherapy 87Bevacizumab 43Radiation 31Carmustine 29Magnetic Resonance Spectroscopy 22Irinotecan 22Erlotinib Hydrochloride 22Chemotherapy, Adjuvant 20Surgical Procedures, Operative 15O(6)-benzylguanine 15Carboplatin 14Radiotherapy, Intensity-Modulated 13Radiotherapy, Conformal 13sargramostim 12Sirolimus 9Imatinib Mesylate 9Filgrastim 9Drug Therapy 9temsirolimus 8Thalidomide 8Sorafenib 8Radiosurgery 8pembrolizumab 7motexafin gadolinium 7aldesleukin 7Vorinostat 7Procarbazine 7Gene Expression Profiling 7Gefitinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × In Situ Hybridization, Fluorescence × Clear all
NCT00424060 2012-09-24

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
38 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡